TRAVERE THERAPEUTICS, INC. Interest and Other Income
TRAVERE THERAPEUTICS, INC. (TVTX) reported Interest and Other Income of $0 for the 3-month period ending 2013-03-31, per its 10-Q/A filed 2013-09-16.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2013-09-16
- TRAVERE THERAPEUTICS, INC. interest and other income for the quarter ending 2013-03-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. interest and other income for the quarter ending 2012-03-31 was -$3.75K.
- TRAVERE THERAPEUTICS, INC. interest and other income for fiscal 2012 was $21.83K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 10 month | Interest and Other Income 12 month | Interest and Other Income 22 month | Interest and Other Income 25 month |
|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 | -$21.91K 10-Q/A · filed 2013-09-16 | |||
| 2012-12-31 | $21.83K 10-K/A · filed 2013-09-16 | $21.91K 10-K/A · filed 2013-09-16 | |||
| 2012-03-31 | -$3.75K 10-Q/A · filed 2013-09-16 | ||||
| 2011-12-31 | $75.00 10-K/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |